Neurofilament Light Chain as a Potential Marker in Behcet's Disease
NCT06060275 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2023-10-11
Summary
To determine the role of neurofilament light chain in Behçet's disease with or without neurological affection and its relation to neurological manifestation (either peripheral or central ).
Conditions
- Behçet
Interventions
- DIAGNOSTIC_TEST
-
serum sample and nerve conduction study and cerebrospinal fluid study
serum sample and cerebrospinal fluid study to detect Neurofilament light chain Nerve conduction study
Sponsors & Collaborators
-
Assiut University
lead OTHER
Principal Investigators
-
Yasmin Makarem · Assiut University
-
Rania Gamal · Assiut University
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-01-01
- Primary Completion
- 2024-10-01
- Completion
- 2024-11-01
More Related Trials
-
Novel MRI Biomarkers for Monitoring Disease Progression in ALS
NCT03362658 ·Status: ACTIVE_NOT_RECRUITING
-
Alpha-synuclein in Cerebrospinal Fluid to Differentiate Alzheimer's Disease From Lewy Body Disease.
NCT01876459 ·Status: UNKNOWN ·Phase: NA
-
Role of Inflammation in Progressive Multifocal Leukoencephalopathy (PML)
NCT01132053 ·Status: COMPLETED
-
New Proteins in Body Fluids as Potential Biomarker for Alzheimer's Disease: a Pilot Study
NCT01773915 ·Status: UNKNOWN
-
Diagnostic Performance of a Commercial Assay for the Detection of Neuronal Antibodies
NCT05783947 ·Status: COMPLETED
-
Modeling Macrophages Activation Pattern in X-linked Adrenoleukodystrophy, Metachromatic Leukodystrophy and Adult Onset Leukoencephalopathy With Axonal Spheroids and Pigmented Glia
NCT04925349 ·Status: RECRUITING
-
Disease Biosignatures in ALS/FTD Spectrum: New Impactful Biological Perspectives Beyond Clinical Approaches
NCT06856850 ·Status: RECRUITING
-
Prognostic Value of Three New Biomarkers of Multiple Sclerosis in Patients With Radiologically Isolated Syndrome
NCT03357887 ·Status: COMPLETED
-
Long-term Effects of SARS-CoV-2 on the Central Nervous System and One-year Follow-up of "Long COVID-19" Patients
NCT05492292 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of Neuroinflamation of SAH
NCT03822260 ·Status: UNKNOWN
-
Contribution of Pathological Alpha-synuclein as a Diagnostic Biomarker for Dementia With Lewy Bodies
NCT07166744 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Neuromelanin MRI: A Progression Marker in Early PD
NCT05631158 ·Status: UNKNOWN
-
Biological Markers for the Diagnosis of Central Nervous System Infective Diseases
NCT02278016 ·Status: UNKNOWN
-
A Monocenter, Cross-sectional Study to Compare Different Type of Cognitive Impairment in Multiple Sclerosis Patients and Cerebrospinal Fluid Biomarkers (Beta Amyloid, Total Tau Protein and Tau-phosphorylated Protein).
NCT00978536 ·Status: TERMINATED ·Phase: NA
-
Magnetic Resonance Spectroscopy, Perfusion and Diffusion Tensor Imaging in Neuropsychiatric Lupus
NCT00723671 ·Status: COMPLETED ·Phase: NA
-
Activity of Cerebral Networks, Amyloid and Microglia in Aging and Alzheimer's Disease
NCT06224920 ·Status: COMPLETED
-
Magnetic Imaging for Diagnostic of Amyotrophic Lateral Sclerosis
NCT04868994 ·Status: RECRUITING ·Phase: NA
-
Natural History and Disease Progression Biomarkers of Multiple System Atrophy
NCT04229173 ·Status: COMPLETED ·Phase: NA
-
Study of Iron Accumulation Measured in MRI in Non-pathological Aging
NCT04659824 ·Status: RECRUITING
-
Determination of COVID-19 Related Virus in Central Nervous System
NCT04775784 ·Status: UNKNOWN
-
Stroke-induced Immunodepression in Neurorehabilitation
NCT05889169 ·Status: COMPLETED
-
Capillary Dysfunction and CD46-immunoreceptor (CD46) Type in MS
NCT03906370 ·Status: COMPLETED
-
Characterization of Immune-response in Autoimmune Encephalitis and Paraneoplastic Neurological Syndromes
NCT05772611 ·Status: RECRUITING
-
Exploring Pathology Related to Slowly Expanding Lesions Using Advanced Imaging
NCT06460077 ·Status: ENROLLING_BY_INVITATION
-
Inflammatory and Infectious Diseases of the Nervous System
NCT02435810 ·Status: RECRUITING